Wednesday 23 April, 2014

Soon, nasal spray vaccines to curb flu

Published On: Tue, Apr 12th, 2011 | Microbiology | By BioNews

Scientists from Albany Medical College, New York, are one step closer in developing a nasal spray that is more effective against flu, pneumonia and even bioterrorism agents, such as Yersinia pestis that causes the plague, than an injection.

They showed how including a natural immune chemical with standard vaccines could boost their protective effect when delivered through the nose.

The respiratory tract is a major entry site for various viral and bacterial pathogens.

However, there are few approved vaccines that can provide optimal protection against them due to the low immune response at muscosal surfaces such as the nasal passage.
Combining standard vaccines for respiratory pathogens with the immune chemical, interleukin-12 (IL-12) and delivering them intranasally to mice has been shown to induce high levels of protection. Vaccines against various respiratory pathogens were tested, including influenza virus, pneumococcal bacteria and Yersinia pestis – a Category A Biothreat. IL-12 is a natural immune chemical, known as a cytokine. It is a powerful stimulator of the immune response through its interactions with other immune chemicals and the white blood cells that produce them.

“Infectious agents still account for around 25 pc of deaths worldwide and the major killers are acute respiratory infections. However, it is difficult to induce immunity at the site of entry and so standard vaccines are only partially protective,” said Prof Dennis Metzger.

“Intranasal vaccination gets around this problem by inducing immunity in the pulmonary passage. This prevents initial infection as well as systemic complications”. Up until now, nasal vaccination has only resulted in sufficient immune responses for very specific types of vaccine. “We now have evidence that this method could work for a wide range of vaccines when IL-12 is included in formulation,” he said.

Nasal vaccines could have a number of other advantages over vaccines that must be injected.

“Vaccination via a nasal spray is a non-invasive procedure that is easier than administering vaccines by injection. In addition our results have shown that antibodies induced by intranasal vaccination are effective not only in preventing infection but can also protect the pulmonary tract in a therapeutic manner after pathogen exposure,” explained Metzger.

“In the case of a bioterrorism threat or an influenza pandemic, this is significant,’ added Metzger.

The study was presented at the Society for General Microbiology”s Spring Conference in Harrogate.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

More from Microbiology
  • Antibiotics may be behind spread of superbug MRSA
  • 26 species of gut bacteria linked to obesity and metabolic syndrome identified
  • `Friendly` tummy bugs could be key to long and healthy life in elderly
  • Scientists discover E coli’s Achilles heel
  • Arsenic-friendly bacteria discovery in Mono Lake refuted
  • Visit us on Google+